Sphere Announces End of Litigation with Gryphon

Stock Information for Vor Biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vor Biopharma Inc.

Kurt Kalbfleisch Named Chief Executive Officer of Sphere 3D Following Interim Leadership Period
Sphere 3D Reports Third Quarter 2025 Financial Results
Sphere 3D Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
Sphere 3D Reports Second Quarter 2025 Financial Results
Sphere 3D Reports First Quarter 2025 Financial Results
Sphere 3D Reports Fiscal Year 2024 Financial Results and Operational Updates
Sphere 3D Announces Passing of Chief Executive Officer
Sphere 3D President and CEO Taking Temporary Leave of Absence

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.